The immune checkpoint molecules PD-L1, PD-L2, and CTLA-4 play a fundamental role in the regulation of immune response towards cancer cells, by suppressing the activation of protective immune cells, e.g., cytotoxic T cells, and promoting immune surveillance, e.g., by recruiting Tregs [60,61,62]. The gene discussed is CTLA4; the disease is cancer.